Santiago-Cardona Pedro G, Pérez-Morales Jaileene, González-Flores Jonathan
Biochemistry and Cancer Biology Divisions, Basic Science Department, Ponce Health Sciences University, Ponce, Puerto Rico.
Methods Mol Biol. 2018;1726:49-64. doi: 10.1007/978-1-4939-7565-5_6.
The retinoblastoma tumor suppressor protein (pRb) is a preeminent tumor suppressor that acts as a cell cycle repressor, specifically as an inhibitor of the G1-S transition of the cell cycle . pRb is a phosphoprotein whose function is repressed by extensive phosphorylation in several key residues, and therefore, pRb's phosphorylation status has become a surrogate for pRb activity. In particular, hyperphosphorylation of pRb has been associated with pathological states such as cancer, and therefore, assessing pRb's phosphorylation status is increasingly gaining diagnostic and prognostic value, may be used to inform therapeutic decisions, and is also an important tool for the cancer biologists seeking an understanding of the molecular etiology of cancer. In this chapter, we discuss an immunoblot protocol to detect pRb phosphorylation in two residues, serine 612 and threonine 821, in protein extracts from cancer cells.
视网膜母细胞瘤肿瘤抑制蛋白(pRb)是一种卓越的肿瘤抑制因子,作为细胞周期抑制因子发挥作用,具体而言是细胞周期G1-S转换的抑制剂。pRb是一种磷蛋白,其功能在几个关键残基上因广泛磷酸化而受到抑制,因此,pRb的磷酸化状态已成为pRb活性的替代指标。特别是,pRb的过度磷酸化与癌症等病理状态相关,因此,评估pRb的磷酸化状态越来越具有诊断和预后价值,可用于指导治疗决策,也是癌症生物学家了解癌症分子病因的重要工具。在本章中,我们将讨论一种免疫印迹方案,用于检测癌细胞蛋白质提取物中两个残基丝氨酸612和苏氨酸821处的pRb磷酸化。